Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Thromb Haemost 2024; 124(03): 250-252
DOI: 10.1055/s-0043-1776010
DOI: 10.1055/s-0043-1776010
Invited Editorial Focus
Venous Thromboembolism and Obesity: Moving Toward a Better Understanding of the Population-Attributable Risk
Funding KAM is supported by a grant from the National Heart, Lung and Blood Institute (K23HL157758).
Publication History
Received: 15 September 2023
Accepted: 18 September 2023
Article published online:
09 October 2023
© 2023. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Obesity and overweight [Internet]. World Health Organization; 2021. . Accessed August 4, 2023 at: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
- 2 Heart disease and stroke statistics—2023 update: a report from the American Heart Association. Accessed September 25, 2023 at: https://www.ahajournals.org/doi/abs/10.1161/CIR.0000000000001123
- 3 Gaugler JO, Righini M, Robert-Ebadi H. et al. Obesity as a predictor for pulmonary embolism and performance of the age-adjusted D-dimer strategy in obese patients with suspected pulmonary embolism. Thromb Haemost 2024; 124 (01) 49-57
- 4 Wang J, Tan J, Hua L, Sheng Q, Huang X, Liu P. Genetic predisposition of both waist circumference and hip circumference increased the risk of venous thromboembolism. Thromb Haemost 2023; 123 (03) 347-361
- 5 Gurunathan U, Barras M, McDougall C, Nandurkar H, Eley V. Obesity and the risk of venous thromboembolism after major lower limb orthopaedic surgery: a literature review. Thromb Haemost 2022; 122 (12) 1969-1979
- 6 Wang T-F, Carrier M, Fournier K, Siegal DM, Le Gal G, Delluc A. Oral anticoagulant use in patients with morbid obesity: a systematic review and meta-analysis. Thromb Haemost 2022; 122 (05) 830-841
- 7 Martin AC, Thomas W, Mahir Z. et al. Direct oral anticoagulant concentrations in obese and high body weight patients: a cohort study. Thromb Haemost 2021; 121 (02) 224-233
- 8 Frischmuth T, Tøndel BG, Brækkan SK, Hansen J-B, Morelli VM. The risk of incident venous thromboembolism attributed to overweight and obesity: the Tromsø study. Thromb Haemost 2024; 124 (03) 239-249
- 9 Population attributable fraction [Internet]. World Health Organization, THE GLOBAL HEALTH OBSERVATORY; 2023. . Accessed August 4, 2023 at: https://www.who.int/data/gho/indicator-metadata-registry/imr-details/1287#:~:text=The%20population%20attributable%20fraction%20is,an%20alternative%20ideal%20exposure%20scenario
- 10 Heit JA, Ashrani A, Crusan DJ, McBane RD, Petterson TM, Bailey KR. Reasons for the persistent incidence of venous thromboembolism. Thromb Haemost 2017; 117 (02) 390-400
- 11 Juul K, Tybjaerg-Hansen A, Schnohr P, Nordestgaard BG, Factor V. Factor V Leiden and the risk for venous thromboembolism in the adult Danish population. Ann Intern Med 2004; 140 (05) 330-337
- 12 Severinsen MT, Overvad K, Johnsen SP. et al. Genetic susceptibility, smoking, obesity and risk of venous thromboembolism. Br J Haematol 2010; 149 (02) 273-279
- 13 Adult obesity facts [Internet]. Centers for Disease Control and Prevention; 2022. . Accessed August 4, 2023 at: https://www.cdc.gov/obesity/data/adult.html
- 14 Zakai NA, McClure LA, Judd SE. et al. Racial and regional differences in venous thromboembolism in the United States in 3 cohorts. Circulation 2014; 129 (14) 1502-1509
- 15 Martin KA, Molsberry R, Cuttica MJ, Desai KR, Schimmel DR, Khan SS. Time trends in pulmonary embolism mortality rates in the United States, 1999 to 2018. J Am Heart Assoc 2020; 9 (17) e016784
- 16 Kubota Y, Cushman M, Zakai N, Rosamond WD, Folsom AR. TV viewing and incident venous thromboembolism: the Atherosclerotic Risk in Communities Study. J Thromb Thrombolysis 2018; 45 (03) 353-359
- 17 Horvei LD, Brækkan SK, Hansen J-B. Weight change and risk of venous thromboembolism: the Tromsø study. PLoS One 2016; 11 (12) e0168878